BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25368331)

  • 1. Tipping the MYC-MIZ1 balance: targeting the HUWE1 ubiquitin ligase selectively blocks MYC-activated genes.
    Schaub FX; Cleveland JL
    EMBO Mol Med; 2014 Dec; 6(12):1509-11. PubMed ID: 25368331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor cell-specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase.
    Peter S; Bultinck J; Myant K; Jaenicke LA; Walz S; Müller J; Gmachl M; Treu M; Boehmelt G; Ade CP; Schmitz W; Wiegering A; Otto C; Popov N; Sansom O; Kraut N; Eilers M
    EMBO Mol Med; 2014 Dec; 6(12):1525-41. PubMed ID: 25253726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc.
    Fieber W; Schneider ML; Matt T; Kräutler B; Konrat R; Bister K
    J Mol Biol; 2001 Apr; 307(5):1395-410. PubMed ID: 11292350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-myc oncoprotein is a transcriptional activator and associates with max and RB1 proteins.
    Wenzel A; Cziepluch C; Schürmann J; Schwab M
    Prog Clin Biol Res; 1994; 385():59-66. PubMed ID: 7972238
    [No Abstract]   [Full Text] [Related]  

  • 5. Viral mutations enhance the Max binding properties of the vMyc b-HLH-LZ domain.
    Crouch DH; Fisher F; La Rocca SA; Goding CR; Gillespie DA
    Nucleic Acids Res; 2005; 33(16):5235-42. PubMed ID: 16166655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Myc/Max/Mad network and the transcriptional control of cell behavior.
    Grandori C; Cowley SM; James LP; Eisenman RN
    Annu Rev Cell Dev Biol; 2000; 16():653-99. PubMed ID: 11031250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K; Anand G; Yin X; Grove L; Prochownik EV
    Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitination of Myc: proteasomal degradation and beyond.
    Müller J; Eilers M
    Ernst Schering Found Symp Proc; 2008; (1):99-113. PubMed ID: 19198066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MULE/HUWE1 E3 ubiquitin ligase is a tumor suppressor.
    Cancer Discov; 2013 Jul; 3(7):OF32. PubMed ID: 23847377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Miz1 and HectH9 regulate the stability of the checkpoint protein, TopBP1.
    Herold S; Hock A; Herkert B; Berns K; Mullenders J; Beijersbergen R; Bernards R; Eilers M
    EMBO J; 2008 Nov; 27(21):2851-61. PubMed ID: 18923429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between Myc and activating transcription factor 2 (ATF2): Myc prolongs the half-life and induces phosphorylation of ATF2.
    Miethe J; Schwartz C; Wottrich K; Wenning D; Klempnauer KH
    Oncogene; 2001 Dec; 20(56):8116-24. PubMed ID: 11781825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HUWE1 upregulation has tumor suppressive effect in human prostate cancer cell lines through c-Myc.
    Qu H; Liu H; Jin Y; Cui Z; Han G
    Biomed Pharmacother; 2018 Oct; 106():309-315. PubMed ID: 29966975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein stabilization: a common consequence of mutations in independently derived v-Myc alleles.
    Gavine PR; Neil JC; Crouch DH
    Oncogene; 1999 Dec; 18(52):7552-8. PubMed ID: 10602514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation.
    Adhikary S; Marinoni F; Hock A; Hulleman E; Popov N; Beier R; Bernard S; Quarto M; Capra M; Goettig S; Kogel U; Scheffner M; Helin K; Eilers M
    Cell; 2005 Nov; 123(3):409-21. PubMed ID: 16269333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ubiquitin ligase Huwe1 regulates the maintenance and lymphoid commitment of hematopoietic stem cells.
    King B; Boccalatte F; Moran-Crusio K; Wolf E; Wang J; Kayembe C; Lazaris C; Yu X; Aranda-Orgilles B; Lasorella A; Aifantis I
    Nat Immunol; 2016 Nov; 17(11):1312-1321. PubMed ID: 27668798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
    Lüscher B; Larsson LG
    Oncogene; 1999 May; 18(19):2955-66. PubMed ID: 10378692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of transcriptional repression by max homodimers.
    Yin X; Grove L; Prochownik EV
    Oncogene; 1998 May; 16(20):2629-37. PubMed ID: 9632139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mimicry: HUWE1 binds an atypical site in MIZ1 by adopting a typical BTB fold.
    Asthana A; Rubin SM
    Structure; 2021 Nov; 29(11):1217-1218. PubMed ID: 34739823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods for the expression, purification, preparation, and biophysical characterization of constructs of the c-Myc and Max b-HLH-LZs.
    Beaulieu ME; McDuff FO; Bédard M; Montagne M; Lavigne P
    Methods Mol Biol; 2013; 1012():7-20. PubMed ID: 24006055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and properties of a Myc derivative that efficiently homodimerizes.
    Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
    Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.